MRVI
Maravai Lifesciences Holdings Inc
Mentions (24Hr)
0.00% Today
Reddit Posts
Keen to get opinion about my progress so far
Would it be a good time to but MRVI and $FCELL energy now to since sentiments r looking like it may surge!
Time to buy this dip. $MRVI n $Fcell
Absolute newb here. I want to understand how to make confident and intelligent choices.
Maravai Life Sciences (MRVi) releases 1st quarter revenue report. An increase of 190% compared to Q1 2020 and a sequential increase of 50% compared to Q4 2020.
Maravai Life Sciences (MRVi) releases first quarter revenue and income. An increase of 190% compared to Q1 2020 and a sequential increase of 50% compared to Q4 2020.
Maravai Life Sciences (MRVi) releases first quarter revenues and income. An increase of 190% compared to Q1 2020 and a sequential increase of 50% compared to Q4 2020
MRVI on it’s way up. I have been still working on a DD but this company has four sectors all in the top of each of their fields of biotech
MRVI on it’s way up. I have been still working on a DD but this company has four sectors all in the top of each of their fields of biotech
MRVI releases news on increased access to mRNA
MRVI Maravai Life Sciences expands mRNA availability
Maravai Life Sciences MRVI expands mRNA availability
Mentions
GH and NTRA have had several approvals/reimbursement wins this year. Not all that close to NEO or VCYT but it seems like their core businesses are humming. TWST and ILMN are derivative plays on the industry so makes sense they'd be up too, though ILMN is more of a complicated product cycle/China story. MRVI is borderline special sits. You're 100% right on the rates argument. But also if you're an institution its much easier to be long Dx vs core tools (typically grouped together) given valuations there and the constant head fake rebounds. Also assume people are starting to shift some money within HC out of biopharma after the YTD run, and Dx gives you some similar factor exposure. Haven't seen much spec dx discussion on reddit since covid, good shit
Research the M&A that happened in the last year, you’ll see real money is flowing back and the valuations are rising. To name a few tickers I personally mentioned here this year: OBIO (at 2.40), ATAI (at 2.05), CMPS (~3), MRVI (2.20), all had even higher highs. The only one of those I’m still holding is OBIO, but the stock I’m really high and long on is DRTS
Of course nobody has only wins, but u/pristine_hurry_4693 has given me BBAI at 2.71, OBIO that moved a bit, MRVI that is down this week but he’s been onto it since about 2$, SRFM, said CMPS will bounce back after it recently got cut in half, ATAI which is the same category, he got me onto Quantum, he’s been preaching Bitcoin since 34K (at least that’s when I heard it from him), I got the CYN run and MLGO (even though that one I miss timed), you get the point… of course I use my own discretion and lately he’s harping on DRTS only, but he’s good
USAR **shh don’t tell anyone** there’s so many, but the five off top of my head: APLD, SEI, MRVI, INOD, AMBA(right now). So many more. Biggest wins have been GOGO, INZY were on there until the skyrocketed and we got out. Those were insane.
Bought MRVI LEAPS calls for pennies and have been watching them bleed…weird blip today, gonna try to sell into it.
MRVI may have committed fraud - buying some cheap calls.
MRVI due to their specialization in mRNA technology. Currently being used in vaccines but has the potential to treat HIV, RSV, cancer, cholesterol. At current levels it provides assymetric upside.
MRVI - Solid across the board. Their numbers are misleading if you don't dig into their reports & earnings calls. Criminally undervalued rn. RCAT - Valuation wise there should be about 10-20% juice left to squeee before becoming overvalued (note that bull races are volatile tho and can overshoot or short term collapse). I'm on the fence of getting in, if short term consolidates within few days and technicals are good I might.
MRVI is the next rocket don’t be late
MRVI 
Just bought 300 shares of MRVI
Totally agree with your take on $MRVI—this is definitely one of those underappreciated gems. The drop in stock price post-COVID is understandable given the decreased demand for mRNA vaccines, but the market seems to be overlooking the long-term potential of CleanCap and the broader applications of their technology. Before the pandemic, their innovative capping technology was a key differentiator in the biotech space, and that hasn’t changed. As the world shifts focus back to other vaccine development and biopharma applications, $MRVI could be poised for a rebound. Definitely a strong pick if you’re willing to take a long-term view on the stock. Interested to see when the market catches up!
I'll be keeping a close eye on several biotech companies, especially MRVI after their possible acquisition news on Friday. It has a lot of room to run this week if the terms of the offer are announced soon. I believe it's unlikely to be accepted as they've turned down offers in the past but the run up could be quite eventful. It's been a rather volatile stock lately, strong support near $8 and strong resistance at $10. I don't see it passing $10 until terms are known, especially since it didn't pass it after 700% increase in volume. Position: 10000s of shares Stop loss: ~$9.10 Exit plan: pending offer details, but expecting to close 25% of my position at $11, 50% at $12-13, and 25% hold
Not that anyone cares, but I’ve been getting really lucky with timing the last month or so. Sold DOCN before earnings. Sold off ZS after earnings and rolled it in to PATH which has had a nice earnings bump. Took a small ALUR position and sold 60% up. Pretty much killed off warrantfolio with minimal losses and moved a big chunk to SKIN last week/yesterday. Biggest mistake was selling THRN on initial deal rumor which left 60% on the table, and buying MRVI before their earnings (~20% tax harvest). Did also lose ~20% on ORGN too, but only had 100 shares to keep an eye on so not much $. What moves are you all making/watching?
$MRVI calls, buyout speculation
All in on MRVI August 20C and hope for buyout
Is MRVI gonna get bought out tomorrow? Buyout offer was made months ago for $42/share. Currently at $11.50/share. $20C pretty cheap $10 each but low liquidity.
I saw that post, and looked into MRVI when I saw it. Definitely seems to be some weird activity...but it seems like a stupid play with no chance, so I bought a few hundred $ worth of calls.
I did some more research. I've found that Biotechne said this in their latest earnings webcast: "M&A remains a top priority for capital allocation." Biotechne recently acquired Lunaphore. They need to borrow \~$2B if they want to acquire MRVI, assuming they are allowed to draw from their revolving credit facility and the addition $400M and allowed to use the capital for the acquisition. Maravai has alot of cash which is nice for Biotechne. It seems logical for Biotechne to aquire Maravai, as they are in the same space(?) (from last maravai conference call) "However, even with our revenue base being the lowest we've seen in almost three years, our margin is still very strong when compared to most companies in our space, including much larger and mature companies. In fact, when we look at the selection of six companies that have reported here already in Q1 2023 and had adjusted EBITDA, including, in alphabetical order: Avantor, Bio-Techne, Danaher, Repligen, Sartorius and Thermo Fisher" (Sartorius offered $42/sh for Maravai in 2022). I think it seems logical for Biotechne to acquire Maravai. The question is whether Maravai will accept or reject the proposal. I believe they will probably reject it, given theyve rejected all other offers (Sartorius, Thomas H. Lee) This is all speculation. probably the next earnings report will provide more information.
>MRVI Well first of all through god **all things are possible** so jot that down
Sold NVTS, may regret it, but hard for me to argue that it’s worth half what it’s skyrocketed up to right now. Put some in to a ORGN, maybe with some actual revenue the market will take a liking. The rest to MRVI which I feel should be finding a bottom with decent financials off the post covid boom and new CEO starting next month. Just think too much takeover interest to not get some market support, and a decent way to play the mRNA pipeline across all.
Other than the ETFs I put most of my portfolio into, my top picks are: NU ABCL ORGN ASTS MRVI VRTX
MRVI jumped out the window, then started falling down the stairs from the Exorcist.
Why is $MRVI halted in PM?
And really, is having 50K karma on WSB really a good thing??? Think about that. Oh, and prior to hawking AXSM in the $20s and low / mid $30s I was explaining MRVI when it was in the mid thirties, before it went to forty, fifty and even up to sixty. But I was out before the top. That's ok.
I’ve been watching MRVI for a while, but concerned they pulled forward too much growth. They’re only looking for 10-12% yoy next year, what’re your views on their go forward?
MRVI- They make biochemistry products, mostly in amino acid chemistry. Their subsidiary Glen Research is excellent: low lead-times, consistently good quality product, good customer support, aggressive invoicing strategy. They get paid, and their YoY growth shows it. They've taken on a lot of debt, but they have the cash on hand to cover it. They're in an aggressive growth phase since their IPO about a year ago, and while their SEC filings have been excellent (consistently beating expectations) their stock price has struggled to stay much above $35 recently due to a secondary offering.
No, before this was MRVI back in May. And I don't hold anything else, so there's no reason to talk about short term trades. But that's cool. However, look when I first started commenting on it. Where was the stock? If I was hype I'd have been gone. Why would I get in and out and blah, blah, blah. Logic.
Hi, is MRVI going to start trending up?
Maravai Lifesciences. Symbol $MRVI. They own Trilink Biotechnologies. They are a key cog in Pfizer/Biontechs mRNA supply chain. In short they produce the Nucleic Acid needed for RNA production. Stock is trading at 24 P/E forward. 180 percent YOY sales growth. Was up 11 percent today, but over 40 percent off its highs.
Good earning for MRVI. MRVI is down around 40 percent good time to buy.
I bought $MRVI when the went IPO last November for $26.50. It's not $45. It was higher but they did a second offering in September, which pissed me off because it was at $66. Still if you want one to hold long term, this is a good one. They are involved with mRNA tech, so all the people taking the fauci sauce are paying this company in some way, and their tech is used in gene therapy cancer treatment. Before they went IPO, they were posting losses, but the losses were "decreasing", and they weren't too terribly over leveraged. They've made money every quarter and beat earnings. So yeah, I expect them to do very well long term.
When it comes to exits, my losses are set at the time i ENTER the position. What does this look like? I buy a stock, and then IMMEIDATELY place a stop market to sell when it falls into an area i never expect the stock to be. Since i only buy stocks near highs, this becomes easy. When the stock falls below the range that I was buying it for, i am out. Another way to put it, when the stock is doing something I didnt plan for, im out. Some recent examples (and i get a lot of stops hit, because i enter a lot of positions) MRVI out at 55.01, MLNK 24.51, CFLT out at 62.01 (this ones going to burn me and go thru highs, i can tell, and thats ok!) As for CRSR, Im actaully in this stock, but i only hold 1 unit, when at one point i had 8 units. Of course, my entry is from 19s and 25. I mostly sold everything in the mid 30s when the stock went parabolic. Commonly when a stock has a BIG move in a short period of time, im going to sell a lot of it. But because the market is what it is, i always hold a bit, no matter where it goes. This is probably why I own over 40 stocks right now. (Yes, all have stops and are self managed) Back for more later.
If I had money, I'd buy a lot of MRVI this week
Maravai Life Sciences MRVI
MRVI- I don’t remember why I bought it. Not sure what they do, but it’s up over 100%, so I’m keeping it!
YOLO stock of the year is 4XSM. Stock down from $51.00 two weeks ago on FDA letter. However, August 22 PDUFA date did not result in AXS-05 denial or Complete Response Letter. FDA is still reviewing this multi focused treatment for depression, smoking and Alzheimer agitation. If drug is approved analysts have targets as high as $165. The downside is, if FDA does eventually reject AXS-05 the stock could take a five to ten dollar hit. And that's big. But the risk / reward of over five to one makes this a worthwhile Super Bet. Plus, the biggest benefit to holding this stock is, AXS-05 application is only for the depression. The other two are still in trials with positive results. There are also two more high quality drugs in the pipeline. I am long at $28.00, $27.10 and $23.35. We could see a four times return as soon as this week. But yes, there is risk. And yes, I am the same trader that told you to buy MRVI at $36.00. Now $60.00.
I'm a bit fan of MRVI. They own Glen Research, which is major supplier for American and European genomics companies. Other than a high debt to cash ratio, their fundamentals are amazing
Hi all, if you took that MRVI trade I called at $35 to $39, now would be a good time to trim about half the position ahead of earnings tonight. Near term $50.00 plus price targets have been hit. The co. could have another great report tonight, but there could be a sell the news reaction. Advice is, hold half for the possibility of a run to a run to $60.00. Then add back on any weakness. OF course, pay attention to the language of guidance. I would not be selling all of this as we still have a significantly higher target. Happy trading. New Pick: AXSM - But this is a longer hold as stock has to reset their AXS-05 NDA position with FDA. Short term volatility in this one. It could go anywhere from here, either to $40-$50 or $20. I would, and have been buying in small parts. Co. has PDUFA date this August 22, but is not expected to advance until certain questions are clarified. But all indications from trial data point to minimal adjustments before the great reset and return to the runway to commercialization.
More like get MRVI, covid is back baby!
Anyone have thoughts on MRVI? I’m bullish
I’m as bullish as ever for MRVI with the covid variant spiking recently. They are a key component in mRNA for vaccines.
MRVI They're a holding company with subsidiaries involved in the genomics pipeline. They've got debt, but they're generating a ton of cash and growing crazy fast. Like, 200% YoY fast
Regret not buying MRVI every fucking day
MRVI has been a beautiful buy... just keeps going up 1-2 % daily.
MRVI has two conferences this week, Blair on Tues, Jefferies Weds and Goldman next week. The UBS conference was amazing. CEO said they are only scratching the surface with their products / services. Trade what you will, but this one is a buy and hold. Not just the moon, but the moons of Jupiter is where MRVI is going.
MRVI Diamond Hold - GREAT NEWS - Yet MORE revenue. It doesn't stop. BioNTech and Pfizer (PFE) announce that the Conditional Marketing Authorization for COMIRNATY in the European Union has been expanded to include individuals 12 to 15 years of age
Only resistance for MRVI is $40. Get through that and it's blue sky, getting high.
MRVI up a dollar yesterday. Up half a buck today. And should be up tomorrow ahead of the roadshow next week. Very good moves the last three days.
MRVI catalysts stacking up. Three upcoming conferences with top tier brokers after an AWESOME meeting with UBS this week. Now we see Pfizer jumping ahead in injecting HS kids. More revenue. I love it. I got the diamonds baby.
https://tickeron.com/ticker/MRVI/?utm_source=stocktwits_free&utm_medium=news&utm_campaign=TICKER_SUMMARY&utm_term=Stock_140543_MRVI&utm_content=category_64_Miscellaneous%20Commercial%20Services
MRVI - Walmart and Sam's Club pharmacies are teaming up with school districts to give adolescents their shot against COVID-19, just in time for summer. Good for Pfizer, good for MRVI. Stock at HoD.
2K share bid for MRVI at $37.40. It won't fill. Watch stock go to $40 by Friday. MRVI to participate in two Healthcare conferences next week. I don't expect much different than the USB call yesterday, but so what. That was an awesome presentation. "Just scratching the surface." CEO Carl Hull.
MRVI - On June 1, 2 and 10 CEO Kevin Herde will participate in Healthcare conferences with William Blair, Jefferies and then CEO Carl Hull will be on with Goldman Sachs. This is a great roadshow. Especially the 10th with Goldman. The UBS conference was extremely positive. Awesome commentary. And the stock responded. Watch for upgrades from all three brokerages. Especially PT raise from GS.
MRVI on a bounce since testing the 50 sma. Should have additional momentum after the UBS Healthcare conference. Very positive. CEO stated "just scratching the surface". You could get a buck for the day or even up to $40 by Friday. Put a bid in AH for $37.50 for a lucky fill. Otherwise, watch the open tomorrow. Spread is usually very wide in the first few minutes. You may be able to get a nice print then. The MM's in this one can be squirrely. They like to up the bid when a retail shows up. But that's also why it can have a great run.
MRVI headed to $40 by Friday? I think so. Amazing chart.
Something cool going on in MRVI today. Closing at HoD.
MRVI HoD into the close. Up over a buck on the day.
If you look at the MRVI daily you'll see a textbook hold and bounce off support. Classic. $40 by Friday after awesome UBS Conference presentation by CEO and CFO.
Every time I pet MRVI it takes a piss on my rug.
MRVI is a great play. Company is solid
MRVI getting ready for vaginal squeeze to $40. Watch. Watch while I fuck.
MRVI shares come with a free pack of pussy
MRVI - Watch the next few days for UBS to do some buying and then upgrade on Monday.
This could be the last chance on MRVI below $40.00. Unusual premarket volume. Stock just up a little, but the there is rarely pre trades. UBS Healthcare Conference presentation, Q&A was amazing. CEO expressed mRNA opportunities was just scratching the surface of potential. PFE has expectations of 4 billion doses of Covid for next year. That's HUGE upside from 2021. MRVI share of vaccines ex covid are expected to exceed industry growth of 25-30%. Also huge. There were many positive comments by the CEO and CFO. Was a great presentation. Stock now up nearly a dollar since typing.
MRVI highlights from UBS Healthcare Conference: Nucleic Acid / mRNA just scratching the surface of potential MRVI reagents are gold standard of the industry Pfizer has projections of 4 Billion covid doses for 2022 Boosters anticipated need every twelve months due to diminished immunity Due to improvements in refrigeration needs more countries expected in coming months MRVI share of Nucleic Acid / mRNA ex covid growth potential should easily exceed industry expectations of 25 to 30% - This alone is worth the current share price Many mRNA treatments reopening, rabies, malaria, hiv, seasonal flu, etc. San Diego facility revenue capacity well above $1 billion Not yet ready to guide for 2022 (great catalyst in my opinion) I am long and buying more. I know many of you will down vote me for saying this, but after reading the last earnings conference call, seeing the massive $100 million plus FY 21 revenue increase guide, then seeing this Q&A with UBS, hearing the CEO saying they are just scratching the surface, I will say, this is one of the greatest potential investments, not trades, but true FOMO investments I have ever seen.
MRVI CEO, Carl Hull: mRNA potential is only scratching the surface. Upside is really quite phenomenal. Really quite bullish. We believe the market may be underestimating. People just don't realize there are .... (many) products available behind covid. Missed the exact phrasing. CFO Kevin Herde: Products are regarded as the gold standard. Great breadth of products. Dominant market share. Taking scale. Further services to customers. Margins are sustainable (65% gm). We like our business model. Looking for M&A targets.
MRVI CFO Kevin Herde: nucleic acid market potential ex covid should grow 25 to 30 pct. with Maravai probably exceeding that. Amazing projection.
MRVI UBS HC conference: Major customer PFE projecting FOUR BILLION covid doses in 2022. AMAZING. UBS asking about 2022 guidance.
MRVI opening comments: CLeanCap is huge driver of growth.
MRVI UBS conference also to include CFO Kevin Herde in addition to CEO Carl Hull.
I'm listening in on MRVI presentation at UBS HC conference. Hasn't begun yet.
MRVI to begin presentation at UBS Healthcare conference in just a few minutes. Hoping for much cheese they raise guidance again.
Every single trader that buys AMC and MRVI gets free pussy through May 31
MRVI presenting at UBS Global Healthcare conference. Worth a shot below $40. If they raise guidance again we're talking about a potential monster move higher. Co. increased guidance three straight months.
MRVI, 70,000 share trade as stock trades up ahead of CEO participation in UBS Global Healthcare conference. Recall, MRVI has raised guidance three consecutive months. Would not be surprised if they increase projections again soon.
New Covid outbreak in Japan. Sorry for the folks getting ill. But more testimony that MRVI will have revenue for as long as there are new strains and different viruses. But of course MRVI also treats all of the ones that have been around forever, Malaria, HIV, flu, etc.
MRVI running ahead of CEO presentation at UBS Healthcare conference. If CEO raises forecasts again, after guiding higher three consecutive months, stock could have an epic run. Low float, low volume could run biggly.
MRVI CEO Carl Hull to present at the UBS Global Healthcare Conference today. Co. has raised guidance three consecutive months. Stated that 2021 is off to a great start and on May 10 increased FY revenue by over a hundred million, from $610 to $720 million. If CEO guides for current quarter, FY or especially 2022 this stock could make that run to $50 we've all been anticipating.
MRVI CEO Carl Hull to present at the UBS Global Healthcare Conference today. Co. has raised guidance three consecutive months. Stated that 2021 is off to a great start and on May 10 increased FY revenue by over a hundred million, from $610 to $720 million.
MRVI. Reopening play, Covid play, massive revenue beat, three straight months of revenue and, or earnings. This is a hold, not a trade.
The only stock in the universe that may be up by 2022 is MRVI. Don't expect it to go to $100 this week. But 2022? I do.
MRVI. Low float, low volume, easy to push, great earnings.
Probably bullish movers today VIAC, cointinued technical bounce, short squeeze PLTR, news, short squeeze SAVA, momentum from Friday peer news MRVI, bounce, continued strength from amazing earnings
MRVi upgraded to bought https://bidaskclub.com/news/company/2021-05-20/MRVI
Nearly 88% of MRVI is owned by institutions. I wonder what they are holding out for? "MRVI) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts." MRVI recently raised FY 21 revenue guidance by up to $100 million, from $610 million to as much as $720 million for the year. I like that. "... according to the analysts, with revenue forecast to display 129% growth on an annualised basis. That is in line with its 114% annual growth over the past year. By contrast, our data suggests that other companies ... in a similar industry are forecast to see their revenues grow 7.5% per year. "
I want to see a PFE bid for MRVI in AH.
MRVI looking great. Up seventh day straight. No big up days, but I'll take it.